alexa Editor - Donald Sikazwe | University of the Incarnate Word | 6229
ISSN: 2169-0138

Drug Designing: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
 
 

Donald Sikazwe

Donald Sikazwe Donald Sikazwe
Feik School of Pharmacy
University of the Incarnate Word
USA
Biography

Dr. Sikazwe earned a PhD in Pharmaceutical Sciences from Florida A & M University.  His dissertation, in the CNS area, focused on design, synthesis, characterization, and evaluation of dopaminereceptor antagonists as potential antipsychotics. He interned at Schering-Plough, and synthesized novel chemical templates for generating anti-inflammatory drug libraries.  He then joined the Medicinal Chemistry Department at Virginia Commonwealth University (VCU) as a Kirschstein-NRSA Postdoctoral Research Fellow (2004 - 2006).  His research at VCU involved rational design, synthesis and structural activity relationship (SAR) development of serotonin-6 receptor ligands for CNS disorders.Thereafter,  he joined the Roskamp Institute (2006) and laterits spin-off biotech Archer Pharmaceuticals Inc. (2008) where he synthesized heterocyclic compounds for Alzheimer’s disease.  In 20009, Dr. Sikazwe joined the Feik School of Pharmacy, San Antonio, TX, where he now teaches Medicinal Chemistry courses.  He has authored several articles and is a holder of two patents.

Research Interest

Discovery of novel chemical agents for treating various disease states, in particular CNS disorders (Alzheimers, Schizophrenia, etc.).

Certificate
Certificate

Global Speakers in the subject

Global Experts in the subject

Publications

The Multi-Target Drug Design Era is Here, Consider it
Donald Sikazwe
Editorial: Drug Design 2012, 1: e101
DOI: 10.4172/2169-0138.1000e101
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]line.com

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version